FLT3 and cutaneous mastocytosis: Finally, by cross validation with the testing group, a valid dataset of 235 CM cases, the expression of the IL7R, FLT3, C1QC, and HLA-DRB5 genes was significantly correlated with patient prognosis (Figure 10).